This concludes our prepared remarks. Thank you for attending this business update, and we'll now open the line for questions.
[Operator Instructions] The first question is from Adnan Butt of RBC Capital Markets.Adnan S. Butt - RBC Capital Markets, LLC, Research Division The first question is on the dosing. So you said for delivery, the assumption is 600 mg over a 14-day course. What could impact of the FDA's decision on dosing? And when you file the NDA first, when do you think you might file it? And secondly, what kind of dosing would you be looking for? Read the rest of this transcript for free on seekingalpha.com